Sunbelt Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$978 Sell
37
-97
-72% -$2.84K ﹤0.01% 2103
2025
Q4
$3.88K Sell
134
-984
-88% -$29.5K ﹤0.01% 1696
2025
Q3
$31K Buy
1,118
+984
+734% +$24.9K ﹤0.01% 1132
2025
Q2
$3.15K Hold
134
﹤0.01% 1529
2025
Q1
$2.78K Hold
134
﹤0.01% 1521
2024
Q4
$3.18K Hold
134
﹤0.01% 1529
2024
Q3
$3.43K Hold
134
﹤0.01% 1520
2024
Q2
$3.15K Sell
134
-60
-31% -$1.51K ﹤0.01% 1476
2024
Q1
$5.58K Hold
194
﹤0.01% 1344
2023
Q4
$6.37K Hold
194
﹤0.01% 1261
2023
Q3
$5.41K Hold
194
﹤0.01% 1294
2023
Q2
$6.61K Hold
194
﹤0.01% 1271
2023
Q1
$5.56K Buy
+194
New +$6.01K ﹤0.01% 1272
2021
Q2
Sell
-2,539
Closed -$225K 443
2021
Q1
$225K Buy
+2,539
New +$252K 0.04% 373

Other funds holding ARKG

Sunbelt Securities's ARKG Position: Q1 2026 in Review

Sunbelt Securities reduced its ARK Genomic Revolution ETF (ARKG) stake by 72% in Q1 2026, selling an estimated $2.84K and leaving 37 shares worth $978. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

Sunbelt Securities first reported a position in ARKG in Q1 2021 and has held it in 14 quarters since. The position peaked at $225K in Q1 2021. 219 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Sunbelt Securities held 37 shares of ARK Genomic Revolution ETF worth $978 as of Q1 2026.
  • Sunbelt Securities sold 97 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $2.84K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2103 holding.
  • Sunbelt Securities first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 14 quarters since.
  • Sunbelt Securities's ARK Genomic Revolution ETF position peaked at $225K in Q1 2021.
  • 219 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.